title: Vical initiates vaccine trials against HSV-2 and CMV.
authors: Eva M
authors: EM
authors: Riedmann
mesh_terms: D000293:Adolescent; D000328:Adult; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D055815:Young Adult; D017321:Clinical Trials, Phase I as Topic; D017322:Clinical Trials, Phase II as Topic; D003587:Cytomegalovirus / Q000276:immunology; D003586:Cytomegalovirus Infections / Q000517:prevention & control; D022482:Cytomegalovirus Vaccines / Q000008:administration & dosage / Q000276:immunology; D006558:Herpes Genitalis / Q000517:prevention & control; D018258:Herpesvirus 2, Human / Q000276:immunology; D022283:Herpesvirus Vaccines / Q000008:administration & dosage / Q000276:immunology; D016032:Randomized Controlled Trials as Topic
chemical_list: D022482:Cytomegalovirus Vaccines; D022283:Herpesvirus Vaccines